loading page

Severe Coronavirus Disease 2019 (COVID-19) Pneumonia Patients Treated Successfully with a Combination of Lopinavir/Ritonavir plus Favipiravir: Case Series
  • +3
  • Hayato Koba,
  • Taro Yoneda,
  • Tomoya Kaneda,
  • Tsukasa Ueda ,
  • Hideharu Kimura,
  • Kazuo Kasahara
Hayato Koba
Komatsu Municipal Hospital
Author Profile
Taro Yoneda
Komatsu Municipal Hospital
Author Profile
Tomoya Kaneda
Komatsu Municipal Hospital
Author Profile
Tsukasa Ueda
Komatsu Municipal Hospital
Author Profile
Hideharu Kimura
Kanazawa University Hospital
Author Profile
Kazuo Kasahara
Kanazawa University Hospital
Author Profile

Abstract

Three COVID-19 patients who were received lopinavir/ritonavir plus favipiravir got to improved without any severe adverse events. Two patients harboring high fever, severe pneumonia and respiratory failure obtained dramatic improvement. The combination therapy might be a treatment option; earlier therapy onset may have needed to avoid lung sequela.

Peer review status:ACCEPTED

20 Jul 2020Submitted to Clinical Case Reports
24 Jul 2020Submission Checks Completed
24 Jul 2020Assigned to Editor
28 Jul 2020Reviewer(s) Assigned
14 Aug 2020Review(s) Completed, Editorial Evaluation Pending
24 Aug 2020Editorial Decision: Revise Minor
25 Aug 20201st Revision Received
26 Aug 2020Submission Checks Completed
26 Aug 2020Assigned to Editor
26 Aug 2020Review(s) Completed, Editorial Evaluation Pending
26 Aug 2020Editorial Decision: Accept